Polyacrylic acid mediated ocular delivery of ribozymes

Journal of Controlled Release

Volumn 38, Issue 2-3, 1996, Pages 167-175

  Ayers, Deborah ^a   Cuthbertson, Jon M ^a   Schroyer, Ken ^b   Sullivan, Sean M ^a,c  

^a Sirna Therapeutics Inc   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CELL GENESYS INC   (United States)

Author keywords

Controlled release; Corneal epithelium; Drug delivery; Polyacrylic acid; Ribozymes

Indexed keywords

CARBOPOL 974; MICROCOCCAL NUCLEASE; PHOSPHORUS 32; POLYACRYLIC ACID; POLYMER; RIBOZYME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG ACCUMULATION; DRUG FORMULATION; EYE; GEL; INTERMETHOD COMPARISON; INTERNALIZATION; LIQUID; MOUSE; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; TECHNIQUE; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION;

EID: 0029870537     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00117-4     Document Type: Article

References (23)

1. S. Biro, Y.M. Fu, Z.X. Yu and S.E. Epstein, Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration, Proc. Natl. Acad. Sci. USA 88 (1993) 1190-1195.
2. T. Skorski, M. Nieborowska-Skorska, N.C. Nicolaides, C. Szcylik, P. Iversen, R.V. Iozzo, G. Zon and B. Calabretta, Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide, Proc. Natl. Acad. Sci. USA 91 (1994) 4504-4508.
3. H. Sawa, B.E. Sobel and S. Fuji, Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cells, J. Biol. Chem. 269 (1994) 14149-14152.
4. J.P. Leonetti, G. Degols, J.P. Clarenc, N. Mechti and B. Lebleu, Cell delivery and mechanism of action of antisense oligonucleotides, Prog. Nucleic Acid Res. Mol. Biol. 44 (1993) 143-166.
5. M. Simons, E.R. Edelman, J.L. DeKeyser, R. Langer and R.D. Rosenberg, Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359 (1992) 67-70.
6. M.R. Bennett, S. Anglin, J.R. McEwan, R. Jagoe, A.C. Newby and G.I. Evan, Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides, J. Clin. Invest. 93 (1994) 820-828.
7. J. Abe, W. Zhou, J. Taguchi, N. Takuwa, K. Miki K, H. Okazaki, K. Kurokawa, M. Kumada and Y. Takuwa, Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery, Biochem. Biophys. Res. Commun. 198 (1994) 16-24.
8. S. Capaccioli, G. Di Pasquale, E. Mini, T. Mazzei and A. Quattrone, Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum, Biochem. Biophys. Res. Commun. 197 (1993) 818-825.
9. C.F Bennett, M.Y. Chiang, H. Chan, J.E. Shoemaker and C.K. Mirabelli, Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides, Mol. Pharmacol. 41 (1992) 1023-1033.
10. X.M. Lu, A.J. Fischman, S.L. Jyawook, K. Hendricks, R.G. Tompkins and M.L. Yarmush, Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake, J. Nucl. Med. 35 (1994) 269-275.
11. T. Skorski, M. Nieborowska-Skorska, N.C. Nicolaides NC; Szczylik, P. Iversen, R.V. Iozzo, G. Zon and B. Calabretta, Suppression of Philadelphia 1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide, Proc. Natl. Acad. Sci. USA 91 (1994) 4504-4508.
12. J.O. Ojwang, A. Hampel, D.J. Looney, F. Wong-Staal and J. Rappaport, Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme, Proc. Natl. Acad. Sci. USA 89:(1992) 10802-10806.
13. M. Yu, J. Ojwang, O. Yamada, A. Hampel, J. Rapapport, D. Looney and F. Wong-Staal. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90 (1993) 8303-8307.
14. D.S. Snyder, Y. Wu, L.W. Quinn, J.J. Rossi, P. Swiderski, B.E. Kaplan and S.J. Forman, Ribozyme-mediated inhibition of bcr-ab1 gene expression in a Philadelphia chromosome-positive cell line, Blood 82 (1993) 600-605.
15. S.K. Shore, P.M. Nabissa and E.P. Reddy, Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity, Oncogene 8 (1993) 3183-3188.
16. J.J. Zhao and L. Pick, Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila, Nature 365 (1993) 448-451.
17. D.Q.M. Craig, S. Tamburic, G. Buckton and J.M. Newton, An investigation into the structure and properties of Carbopol® 934 gels using dielectric spectroscopy and oscillatory rheometry, J. Control. Release 30 (1994) 213-223.
18. S.A. Scaringe, C. Franklyn and N. Usman, Chemical synthesis of biologically active oligoribonucleotides using β-cyanoethyl protected ribonucleoside phosphoramidites, Nucleic Acids Res. 18 (1990) 5433-5441.
19. S.L. Loke, C.A. Stein, X.H. Zhang, K. Mori, M. Nakanishi, C. Suvasinghe, J.S. Cohen and L.M. Neckers, Characterization of oligonucleoitde transport in living cells. Proc. Natl. Acad. Sci. USA 86 (1989) 3474-3478.
20. L.A. Yakubov, E.A. Deeva, V.F. Zarytova, E.M. Ivanova, A.S. Ryte, L.V. Yurchenko and V. Vlasso, Mechanism of oligonucleotide uptake by cells: involvement of specific receptors. Proc. Natl. Acad. Sci. 86 (1989) 6454-6458.
21. L. Yakubov, L. Yurchenko, M. Nechaeva, E. Rykova, V. Karamyshev, J. Tonkinson, V. Vlassov and C.A. Stein, Interaction of oligonucleotides with cellular receptors, Nucleic Acids Res. Symp. Ser. 24 (1991) 311.
22. N.M. Davies, S.J. Fair, J. Hadgraft and I.W. Kellaway, Evaluation of mucoadhesive polymers in ocular drug delivery. I. viscous solutions, Pharm. Res. 8 (1991) 1039-1043.
23. P. Artursson and C. Magnusson, Epithelial transport of drugs in cell culture. I: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells, J. Pharm. Sci. 79 (1990) 595-600.